Improved survival of murine island skin flaps by prevention of reperfusion injury

Plastic and Reconstructive Surgery

Volumn 123, Issue 5, 2009, Pages 1431-1439

  Tatlidede, Soner H ^a   Murphy, Adrian D ^a   McCormack, Michael C ^a   Nguyen, John T ^a   Eberlin, Kyle R ^a   Randolph, Mark A ^a   Moore, Francis D ^a   Austen, William G ^a  

^a Room 629 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P8; P8 PEPTIDE; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPOSITE GRAFT; CONTROLLED STUDY; DRUG EFFECT; GRAFT NECROSIS; ISCHEMIA; ISLAND FLAP; MALE; MAMMARY ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SKIN FLAP; ANIMAL; C57BL MOUSE; DISEASE MODEL; GRAFT SURVIVAL; NECROSIS; PATHOLOGY; PLASTIC SURGERY; SKIN; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; MALE; MICE; MICE, INBRED C57BL; NECROSIS; PEPTIDES; REPERFUSION INJURY; SKIN; SURGICAL FLAPS;

EID: 66549118844     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181a071e8     Document Type: Article

References (42)

1. Carroll WR, Esclamado RM. Ischemia/reperfusion injury in microvascular surgery. Head Neck 2000;22:700-713.
2. Hill JH, Ward PA. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med. 1971; 133:885-900.
3. Khalil AA, Aziz FA, Hall JC. Reperfusion injury. Plast Reconstr Surg. 2006;117:1024-1033.
4. HillJ,Lindsay TF, OrtizF,Yeh CG, Hechtman HB, Moore FD Jr. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol. 1992;149:1723-1728.
5. Huang J, Kim LJ, Mealey R, et al. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999;285:595-599.
6. Kyriakides C, Wang Y, Austen WG Jr, et al Moderation of skeletal muscle reperfusion injury by a sLe(x)-glycosylated complement inhibitory protein. AmJ Physiol. 2001;281:C224- C230.
7. Lehmann TG, Koeppel TA, Munch S, et al. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia. Microvasc Res. 2001;62:284-292.
8. Stammberger U, Hamacher J, Pache JC, Schmid RA. sCR1sLe(X) reduces lung allograft ischemia-reperfusion injury but does not ameliorate acute rejection. Eur J Cardiothorac Surg. 2002;22:368-372.
9. Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990;249:146-151.
10. Zacharowski K, Otto M, Hafner G, Marsh HC Jr, Thiemermann C. Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x. Br J Pharmacol. 1999;128:945-952.
11. Weiser MR, Williams JP, Moore FD Jr, et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med. 1996;183:2343-2348.
12. Williams JP, Pechet TT, Weiser MR, et al. Intestinal reper-fusion injury is mediated by IgM and complement. J Appl Physiol. 1999;86:938-942.
13. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 1995;92:8031-8035.
14. Buerke M, Prufer D, Dahm M, Oelert H, Meyer J, Darius H. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther. 1998;286:429-438.
15. Arumugam TV, Shiels IA, Woodruff TM, Reid RC, Fairlie DP, Taylor SM. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. J Surg Res. 2002;103:260-267.
16. Wada K, Montalto MC, Stahl GL. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology 2001;120: 126-133.
17. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: Role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 1998;97:2259-2267.
18. Zhang M, Austen WG Jr, Chiu I, et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA. 2004; 101:3886-3891.
19. Austen WG Jr, Zhang M, Chan R, et al. Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM. Surgery 2004;136:401-406.
20. Zhang M, Alicot EM, Chiu I, et al. Identification of the target self-antigens in reperfusion injury. J Exp Med. 2006;203:141- 152.
21. Chan RK, Ding G, Verna N, et al. IgM binding to injured tissue precedes complement activation during skeletal muscle ischemia-reperfusion. J Surg Res. 2004;122:29-35.
22. Murry CJ, Jenings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
23. Cleveland JC Jr, Wollmering MM, Meldrum DR, et al. Ischemic preconditioning in human and rat ventricle. Am J Physiol. 1996; 271:H1786-H1794.
24. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-277.
25. Yoshizumi T, Yanaga K, Soejima Y, Maeda T, Uchiyama H, Sugimachi K. Amelioration of liver injury by ischaemic preconditioning. Br J Surg. 1998;85:1636-1640.
26. Schroeder CA Jr, Lee HT, Shah PM, Babu SC, Thompson CI, Belloni FL. Preconditioning with ischemia or adenosine protects skeletal muscle from ischemic tissue reperfusion injury. J Surg Res. 1996;63:29-34.
27. Carroll CM, Carroll SM, Overgoor ML, Tobin G, Barker JH. Acute ischemic preconditioning of skeletal muscle prior to flap elevation augments muscle-flap survival. Plast Reconstr Surg. 1997;100:58-65.
28. Zahir KS, Syed SA, Zink JR, Restifo RJ, Thomson JG. Ischemic preconditioning improves the survival of skin and myocuta-neous flaps in a rat model. Plast Reconstr Surg. 1998;102:140- 150; discussion 151-142.
29. Coskunfirat OK, Ozkan O, Dikici MB. The effect of ischemic preconditioning on secondary ischemia in skin flaps. Ann Plast Surg. 2006;57:431-434.
30. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG auto-antibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA. 2000;97:1184-1189.
31. Suber F, Carroll MC, Moore FD Jr. Innate response to self-antigen significantly exacerbates burn wound depth. Proc Natl Acad Sci USA. 2007;104:3973-3977.
32. Siemionow M, Arslan E. Ischemia/reperfusion injury: A review in relation to free tissue transfers. Microsurgery 2004;24: 468-475.
33. Kagiyama A, Savage HE, Michael LH, Hanson G, Entman ML, Rossen RD. Molecular basis of complement activation in ischemic myocardium: Identification of specific molecules of mitochondrial origin that bind human C1q and fix complement. Circ Res. 1989;64:607-615.
34. Rossen RD, Michael LH, Kagiyama A, et al. Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circ Res. 1988;62:572-584.
35. Kantor AB, Herzenberg LA. Originofmurine Bcell lineages. Annu Rev Immunol. 1993;11:501-538.
36. Fleming SD, Shea-Donohue T, Guthridge JM, et al. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol. 2002;169:2126-2133.
37. Reid RR, Woodcock S, Shimabukuro-Vornhagen A, et al. Functional activity of natural antibody is altered in Cr2-de-ficient mice. J Immunol. 2002;169:5433-5440.
38. Padilla ND, van Vliet AK, Schoots IG, et al. C-reactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion. Surgery 2007;142:722-733.
39. Zhang M, Alicot EM, Carroll MC. Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model. Mol Immunol. 2008;45:4036-4039.
40. Krijnen PA, Ciurana C, Cramer T, et al. IgM colocalises with complement andC reactive protein in infarcted human myocardium. J Clin Pathol. 2005;58:382-388.
41. Chan RK, Verna N, Afnan J, et al. Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Surgery 2006;139:236- 243.
42. Bresnick AR. Molecular mechanisms of nonmuscle myosin-II regulation. Curr Opin Cell Biol. 1999;11:26-33.